SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

XENE

Xenon Pharmaceuticals Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 12h ago SEC0000315066-26-002888
Passive stake amendment
Actionable Insight • Neutral

Monitor for any conversion of this 13G to a 13D, which would signal activist intent. The passive stake is routine and does not indicate a change in investment thesis.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$37.68
T+0 close · Nov 5, 2026 · via day close
Latest settled
+8.80%
T+5 · $41.00
Vs SPY
+5.51%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $37.68entry
  2. T+1 · 11d ago +3.95%α +3.64% · $39.17
  3. T+5 · 5d ago +8.80%α +5.51% · $41.00
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 11,136,649 shares of Xenon Pharmaceuticals Inc. as of September 30, 2026, representing 11.5% of outstanding common stock. This is a routine quarterly update by a passive institutional investor; the stake level is consistent with prior filings.

Key Financial Metrics

Stake
11.5%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reported beneficial ownership of 11,136,649 shares of Xenon Pharmaceuticals common stock as of September 30, 2026.
  • The stake represents 11.5% of outstanding shares.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent.
  • Fidelity Management & Research Company LLC beneficially owns 5% or greater of the outstanding shares.

Financial Impact

FMR LLC holds 11.5% of Xenon Pharmaceuticals, valued at approximately $425.5 million based on the $3.7B market cap.

ownership_percentage

Risk Factors

  • No material risks identified from this routine passive stake filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002888
Document: 0000315066-26-002888-index-headers.html0000315066-26-002888
Document: 0000315066-26-002888-index.html0000315066-26-002888
Document: 0000315066-26-002888.txt0000315066-26-002888

Track record

19 reports on XENE

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +18.60% at T+60 after the Apr 19, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $40.11 Now $39.26 −2.12% settles Nov 17
  2. Nov 9, 20267d ago 8-K Neutral 5/10 Entry $41.39 to $42.10 Now $39.26 −5.15% ▲ +1.72% +0.40% vs SPY
  3. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $39.17 to $40.45 Now $39.26 +0.23% ▲ +3.27% +0.90% vs SPY
  4. Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $39.17 to $40.45 Now $39.26 +0.23% ▲ +3.27% +0.90% vs SPY
  5. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $37.68 to $39.17 Now $39.26 +4.19% ▲ +3.95% +3.64% vs SPY
  6. Nov 3, 202613d ago Press Release Neutral 2/10 Entry $39.19 to $37.68 Now $39.26 +0.18% ▼ −3.85% +0.56% vs SPY
  7. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $38.23 to $39.19 Now $39.26 +2.69% ▲ +2.51% +0.86% vs SPY
  8. Oct 1, 20266w ago Insider Cluster Bullish 6/10 Entry $38.93 to $38.02 Now $39.26 +0.85% ▼ −2.34% −3.08% vs SPY
  9. Jul 2, 202619w ago Press Release Neutral 1/10 Entry $60.96 to $60.54 Now $39.26 −35.60% ▼ −0.69% −1.56% vs SPY
  10. Jun 5, 202623w ago 144 Neutral 2/10 Entry $51.21 to $52.79 Now $39.26 −23.34% ▲ +3.09% +3.38% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 7h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026